Suven Life Sciences Q1 Results
- BSE: 530239
- NSE: SUVEN
- ISIN: INE495B01038
- Sector: Biotechnology & Drugs
BSE
306.55
-2.80 (-0.91%)
-2.80 (-0.91%)Volume31.81 K
Updated: Wed 7 Oct, 2026 | 15:28:28
NSE
305.55-3.60 (-1.16%)
-3.60 (-1.16%)Volume3.11 L
Updated: Wed 7 Oct, 2026 | 15:31:54
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹3.57 Cr.(91.02%)
- Operating Profit₹-,134.66 Cr.(158.38%)
- Profit After Tax₹-,127.61 Cr.(147.71%)
- Operating Margin-3776.37%(35.26%)
Note: Comparison is on YoY basis
Quarterly - Suven Life Sciences Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 138.22 | 53.74 | 157.23% | 33.03 | 156.05% |
| Depreciation/ Amortization | 2.16 | 1.58 | 36.18% | 1.49 | 57.49% |
| Operating Income | -,134.66 | -52.22 | 157.89% | -32.02 | 158.38% |
| Net Income | -,127.61 | -45.60 | 179.87% | -28.04 | 147.71% |
| Net Income Before Taxes | -,127.61 | -45.60 | 179.87% | -28.04 | 147.71% |
| Other Operating Expenses Total | 4.96 | 3.99 | 24.11% | 1.94 | -3.79% |
| Total Revenue | 3.57 | 1.52 | 134.58% | 1.01 | 91.02% |
| Selling/ General/ Admin Expenses Total | 7.28 | 5.83 | 24.93% | 4.69 | 21.86% |
| Diluted Normalized EPS | -4.84 | -1.90 | 154.60% | -1.29 | 104.88% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.